OFFICIAL PUBLICATION OF

by its subsidiary APPco

PBS funding for vigabatrin substitution

Nicholas O’Donoghue 15/09/2023

PBS confirms subsidy arrangements for vigabatrin under a serious scarcity substitution instrument (SSSI) An amendment to the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021 to enable Pharmaceutical Benefits Scheme (PBS) subsidies for the supply of different forms of vigabatrin under an SSSI. The Therapeutic Goods Administration (TGA) announced

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

CAPS rep lands seat on Guild committee

Good luck to all Guild candidates. I am hopeful that all candidates have nominated for the right reasons - that…

Phillip Wade

Gender pay gap must be addressed

I have to disagree. Since 2008, anyone considering a Pharmacy degree had access to a wealth of online information, including…

Dan Abedini

Costs hinder recruitment of overseas pharmacists

Pharmacy needs the same thing as all allied health. Pay rises commensurate with experience and responsibilities. You can literally have…

Bob Tran

HMC Capital ups its share in Sigma…again

"Sigma CEO Vikesh Ramsunder In October last year said he saw HMC’s interest not as a takeover play but “as…

Bart Pharm

PBS funding for vigabatrin substitution

Previous Limited uptake of 60-day scripts

Next Overcoming the language barrier

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous Limited uptake of 60-day scripts

Next Overcoming the language barrier

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.